Loss of histidine decarboxylase as a marker of malignant transformation and dedifferentiation of B-cells infiltrating the skin. A case report of a therapy-resistant multiple myeloma complicated by skin infiltration.
Varkonyi
Judit
J
Karádi
István
I
Szocs
Katalin
K
Sugár
István
I
Sápi
Zoltán
Z
Marschalko
Márta
M
Pállinger
Eva
E
Darvas
Zsuzsanna
Z
Falus
András
A
D000368:Aged; D001402:B-Lymphocytes / Q000201:enzymology / Q000473:pathology*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001853:Bone Marrow / Q000473:pathology; D054337:Cell Dedifferentiation; D002471:Cell Transformation, Neoplastic; D017809:Fatal Outcome; D005260:Female; D006632:Histamine / Q000378:metabolism; D006640:Histidine Decarboxylase / Q000032:analysis*; D006801:Humans; D009101:Multiple Myeloma / Q000737:chemistry / Q000188:drug therapy / Q000201:enzymology / Q000473:pathology*; D009363:Neoplasm Proteins / Q000032:analysis*; D010950:Plasma Cells / Q000201:enzymology / Q000473:pathology; D012867:Skin / Q000473:pathology*; D053668:Syndecan-1 / Q000032:analysis
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; C508241:SDC1 protein, human; D053668:Syndecan-1; D006632:Histamine; D006640:Histidine Decarboxylase